Literature DB >> 18179384

A moving target: the multiple roles of CCR5 in infectious diseases.

Robyn S Klein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179384     DOI: 10.1086/524692

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  11 in total

1.  Double-edged genetic swords and immunity: lesson from CCR5 and beyond.

Authors:  Sunil K Ahuja; Weijing He
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

2.  Staphylococcus aureus and CCR5: unveiling commonalities in host-pathogen interactions and potential treatment strategies.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

3.  The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis.

Authors:  Maximilian Larena; Matthias Regner; Mario Lobigs
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

4.  The expression of the chemokine receptor CCR5 in tick-borne encephalitis.

Authors:  Sambor Grygorczuk; Joanna Osada; Miłosz Parczewski; Anna Moniuszko; Renata Świerzbińska; Maciej Kondrusik; Piotr Czupryna; Justyna Dunaj; Milena Dąbrowska; Sławomir Pancewicz
Journal:  J Neuroinflammation       Date:  2016-02-22       Impact factor: 8.322

Review 5.  Genetic Modulation Therapy Through Stem Cell Transplantation for Human Immunodeficiency Virus 1 Infection.

Authors:  Varshil Mehta; Divya Chandramohan; Shivika Agarwal
Journal:  Cureus       Date:  2017-03-13

6.  Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers.

Authors:  Hanna Jerome; Callum Taylor; Vattipally B Sreenu; Tanya Klymenko; Ana Da Silva Filipe; Celia Jackson; Chris Davis; Shirin Ashraf; Eleri Wilson-Davies; Natasha Jesudason; Karen Devine; Lisbeth Harder; Celia Aitken; Rory Gunson; Emma C Thomson
Journal:  J Infect       Date:  2019-08-06       Impact factor: 6.072

7.  Host polymorphisms and COVID-19 infection.

Authors:  Joris R Delanghe; Marijn M Speeckaert
Journal:  Adv Clin Chem       Date:  2021-08-23       Impact factor: 5.394

8.  The CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population.

Authors:  Alvino Maestri; Mirleide Cordeiro dos Santos; Elzemar M Ribeiro-Rodrigues; Wyller Alencar de Mello; Rita Catarina Medeiros Sousa; Sidney Emanuel dos Santos; Vinicius Albuquerque Sortica
Journal:  BMC Res Notes       Date:  2015-07-30

Review 9.  Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease.

Authors:  Anandi Rautenbach; Aurelia A Williams
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

Review 10.  Chemokine receptor gene polymorphisms and COVID-19: Could knowledge gained from HIV/AIDS be important?

Authors:  Rajeev K Mehlotra
Journal:  Infect Genet Evol       Date:  2020-08-26       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.